Rule 16 – Examination as to formal requirements of the Statement of claim
Content
1. The Registry shall as soon as practicable check whether the patent concerned is the subject of an opt-
out pursuant to Article 83(3) of the Agreement and Rule 5. In the event of an opt-out the Registry shall
as soon as practicable inform the claimant who may withdraw or amend the Statement of claim as
appropriate.
2. The Registry shall, as soon as practicable after the lodging of the Statement of claim, examine whether
the requirements of Rules 13.1 (a) to (j), .2, 14 and 15.1 have been complied with.
3. If the claimant has not complied with the requirements referred to in paragraph 2, the Registry shall
as soon as practicable invite the claimant to:
(a) correct the deficiencies within 14 days of service of such notification; and
(b) where applicable, pay the fee for the infringement action within said 14 days.
4. The Registry shall at the same time inform the claimant that if the claimant fails to correct the
deficiencies or pay the fee within the time stated, a decision by default may be given, in accordance with
Rule 355.
5. If the claimant fails to correct the deficiencies or pay the fee, the Registry shall inform a judge of the
division who may reject the action as inadmissible by a decision by default. The judge may give the
claimant an opportunity to be heard beforehand.
Related Cases
- UPC_CFI_145/2024; 146/2024; 147/2024; 148/2024; 463/2024; 496/2024; 374/2024; 503/2024 – Sanofi v Accord, Stada, Reddy and Zention
- UPC CoA 335/2023 – 10x Genomics, Inc. and President and Fellows of Harvard College v NanoString Technologies Inc, NanoString Technologies Germany GmbH and NanoString Technologies Netherlands B.V.
- UPC CFI 17/2023 – 10x Genomics, Inc. and President and Fellows of Harvard College v NanoString Technologies Inc, NanoString Technologies Germany GmbH, NanoString Technologies Netherlands B.V., Brad Gray, Mark James Daniel, and Björn Kristian Johnson
- UPC_CFI_17/2023 – 10x Genomics, Inc. and President and Fellows of Harvard College v NanoString Technologies Inc. et al.
- UPC CFI 2/2023 – 10x Genomics, Inc. and President and Fellows of Harvard College v NanoString Technologies Inc., NanoString Technologies Germany GmbH and NanoString Technologies Netherlands B.V.